• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫反应效应机制缺陷与自身免疫

Deficiency of the effector mechanisms of the immune response and autoimmunity.

作者信息

Lachmann P J, Walport M J

机构信息

Mechanisms in Tumour Immunity Unit, MRC Centre, Cambridge, UK.

出版信息

Ciba Found Symp. 1987;129:149-71. doi: 10.1002/9780470513484.ch11.

DOI:10.1002/9780470513484.ch11
PMID:2960501
Abstract

It has long been the conventional wisdom that most autoimmune responses represent a pathological aberration of the immune system and a great deal of effort has been devoted to investigating how such abnormal responses may be induced. It seems likely, however, particularly in the form of autoimmunity seen in diseases like systemic lupus erythematosus (LE) and associated with immune complex disease, that it is not the induction of the autoimmune response that is primarily abnormal, but its persistence, and that this abnormal persistence is a consequence of a failure of the proper functioning of the effector mechanisms of the immune response. The strongest reason for so believing is the striking incidence of these diseases in subjects with deficiencies of the early components of the classical complement pathway. Total, homozygous deficiencies are rare and account for only a small proportion of patients with systemic LE. However, partial, heterozygous deficiency of these components is much commoner and also carries an increased susceptibility to these diseases. An explanation for this association is given. In the presence of an adequately functioning complement system immune complexes remain soluble and of relatively small size. It is proposed that this is a result of the incorporation of C4 and C3 into the antigen-antibody lattice leading to a reduction in the effective valency of antigen and antibody. The Goldberg theory of immune precipitation predicts that a reduction in valency would inhibit precipitation and the formation of large complexes. In the absence of adequate complement function this mechanism will fail and large, potentially insoluble complexes with little C4 and C3 on them will be formed. These large immune complexes without sufficient C4 and C3 bound on them will also not be bound normally to erythrocyte CR1 and will therefore be transported in the (peripheral) plasma stream rather than in the (central) erythrocyte stream. It is proposed that this will result in the deposition of immune complexes in peripheral small blood vessels rather than in the sinusoids of the liver and spleen; and that this peripheral deposition gives rise to inflammation, with the release of autoantigens and the formation of further autoantibodies. The importance of CR1 in relation to these diseases is emphasized by the reduction in CR1 numbers that accompanies their active phase. This appears to be due to proteolysis of the receptor while the immune complex-bearing erythrocyte is sequestered in the reticuloendothelial system.

摘要

长期以来,传统观点认为大多数自身免疫反应代表免疫系统的病理异常,人们投入了大量精力来研究这种异常反应是如何诱导产生的。然而,特别是在系统性红斑狼疮(LE)等疾病中出现的自身免疫形式,并与免疫复合物疾病相关联的情况下,似乎主要异常的并非自身免疫反应的诱导,而是其持续性,并且这种异常持续性是免疫反应效应机制正常功能失败的结果。如此认为的最有力理由是,在经典补体途径早期成分缺乏的个体中,这些疾病的发病率惊人。完全的纯合子缺乏很少见,仅占系统性LE患者的一小部分。然而,这些成分的部分杂合子缺乏则更为常见,并且也会增加患这些疾病的易感性。文中给出了这种关联的一种解释。在补体系统功能正常的情况下,免疫复合物保持可溶且尺寸相对较小。据推测,这是由于C4和C3掺入抗原 - 抗体晶格导致抗原和抗体的有效价降低的结果。戈德堡免疫沉淀理论预测,价的降低会抑制沉淀和大复合物的形成。在缺乏足够补体功能的情况下,该机制将失效,会形成带有少量C4和C3的大的、潜在不溶性复合物。这些没有足够C4和C3结合在其上的大免疫复合物也不会正常地与红细胞CR1结合,因此将在(外周)血浆流中运输,而不是在(中央)红细胞流中运输。据推测,这将导致免疫复合物在外周小血管中沉积,而不是在肝脏和脾脏的血窦中沉积;并且这种外周沉积会引发炎症,释放自身抗原并形成更多自身抗体。在这些疾病的活动期,CR1数量的减少强调了CR1与这些疾病的相关性。这似乎是由于在免疫复合物携带的红细胞被隔离在网状内皮系统时,受体发生了蛋白水解作用。

相似文献

1
Deficiency of the effector mechanisms of the immune response and autoimmunity.免疫反应效应机制缺陷与自身免疫
Ciba Found Symp. 1987;129:149-71. doi: 10.1002/9780470513484.ch11.
2
Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.抗原在脾脏边缘区的定位可恢复补体C4缺陷小鼠的体液免疫反应和IgG类别转换。
Int Immunol. 2004 Dec;16(12):1685-90. doi: 10.1093/intimm/dxh159. Epub 2004 Oct 11.
3
Control of immune complexes by the classical pathway.经典途径对免疫复合物的调控
Behring Inst Mitt. 1989 Jul(84):111-20.
4
Complement deficiency and the pathogenesis of autoimmune immune complex disease.补体缺陷与自身免疫性免疫复合物疾病的发病机制。
Chem Immunol. 1990;49:245-63.
5
Complement deficiency. Predisposing factor to autoimmune syndromes.补体缺陷。自身免疫综合征的易感因素。
Am J Med. 1988 Dec 23;85(6A):45-7. doi: 10.1016/0002-9343(88)90383-x.
6
Complement deficiency: predisposing factor to autoimmune syndromes.补体缺陷:自身免疫综合征的易感因素。
Clin Exp Rheumatol. 1989 Sep-Oct;7 Suppl 3:S95-101.
7
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.补体C4通过一种独立于补体受体CR1和CR2的机制抑制全身性自身免疫。
J Exp Med. 2000 Nov 6;192(9):1339-52. doi: 10.1084/jem.192.9.1339.
8
Inhibition of immune precipitation by complement.补体对免疫沉淀的抑制作用。
J Immunol. 1984 Sep;133(3):1464-70.
9
Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement.肼屈嗪和异烟肼可减少补体介导的可溶性免疫复合物的形成。
Immunol Lett. 1985;9(5):297-9. doi: 10.1016/0165-2478(85)90011-2.
10
Complement components and receptors: deficiencies and disease associations.补体成分与受体:缺陷及疾病关联
Immunol Ser. 1990;52:33-51.

引用本文的文献

1
Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.免疫球蛋白的氨甲酰化作用可消除经典补体途径的激活。
Eur J Immunol. 2014 Nov;44(11):3403-12. doi: 10.1002/eji.201444869. Epub 2014 Oct 20.
2
Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.自身免疫性疾病中免疫沉淀预防缺陷与C4A*Q0无关。
Clin Exp Immunol. 2005 Jun;140(3):572-9. doi: 10.1111/j.1365-2249.2005.02794.x.
3
Complement and systemic lupus erythematosus.补体与系统性红斑狼疮
Arthritis Res. 2002;4 Suppl 3(Suppl 3):S279-93. doi: 10.1186/ar586. Epub 2002 May 9.
4
Immune complex processing in C1q-deficient mice.C1q缺陷小鼠中的免疫复合物处理
Clin Exp Immunol. 2001 Feb;123(2):196-202. doi: 10.1046/j.1365-2249.2001.01459.x.
5
Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.经典补体途径蛋白C2和C4的联合杂合缺陷
J Clin Immunol. 1997 Mar;17(2):176-84. doi: 10.1023/a:1027334716982.
6
Complement deficiency and immune complex disease.补体缺陷与免疫复合物疾病
Springer Semin Immunopathol. 1994;15(4):397-416. doi: 10.1007/BF01837367.
7
Hereditary C6 deficiency in a strain of PVG/c rats.一种PVG/c大鼠品系中的遗传性C6缺乏症。
Clin Exp Immunol. 1994 Sep;97(3):478-82. doi: 10.1111/j.1365-2249.1994.tb06113.x.
8
The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.正常受试者和系统性红斑狼疮患者体内衰老红细胞CR1的丢失率:与结构或数量多态性无关。
Clin Exp Immunol. 1988 Apr;72(1):74-8.
9
The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.低补体血症和低红细胞I型补体受体数量在人类异常免疫复合物清除中的作用。
Clin Exp Immunol. 1989 Mar;75(3):329-35.
10
Molecular basis of hereditary C3 deficiency.遗传性C3缺乏症的分子基础。
J Clin Invest. 1990 Oct;86(4):1158-63. doi: 10.1172/JCI114821.